Athersys Email Format
Biotechnology ResearchOhio, United States11-50 Employees
Athersys is a clinical-stage biotechnology company based in Cleveland, Ohio, pursuing discovery and development of therapies intended to extend and improve the quality of life for people with significant and life-threatening diseases. The company maintains a pipeline that includes both stem cell-based therapies and traditional pharmaceuticals, developed through its proprietary technologies. Its work centers on applying regenerative medicine and novel medicines to address critical care and other severe conditions. Within the biotechnology research landscape, Athersys positions itself through a diversified portfolio of programs across multiple disease areas, including regenerative cell therapies alongside conventional drug candidates. A notable development is the interim analysis of the Phase 3 MASTERS-2 trial evaluating MultiStem for ischemic stroke, illustrating ongoing clinical progress in its pipeline.